Alliance Wealth Advisors »

Alnylam Pharmaceuticals shares owned by Alliance Wealth Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Alliance Wealth Advisors from 13F filings

Historical chart of Alliance Wealth Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Alliance Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Alliance Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $230k 504 456.00

More positions owned by Alliance Wealth Advisors

Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Oracle Corporation (ORCL)
Amazon (AMZN)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Visa Com Cl A (V)
J P Morgan Exchange Traded F Betabuldrs Japan (BBJP)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Shopify Cl A Sub Vtg Shs (SHOP)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Netflix (NFLX)
Ishares Tr 0-5 Yr Tips Etf (STIP)

View all positions for Alliance Wealth Advisors

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals